Newsroom | 5474 results
Sorted by: Latest
-
New Research Shows Virta Health Cuts Depression by 44% and Anxiety by 30%
DENVER--(BUSINESS WIRE)--New clinical studies from Virta Health, the leader in metabolic disease reversal, show how Virta’s individual nutrition therapy and AI-powered, clinical care can drastically improve the health of adults living with obesity. The research abstracts, presented at ObesityWeek 2026, revealed Virta members showed noticeable improvements across mental health, cognitive function, sleep, physical pain, and workplace productivity, with or without the use of GLP-1s. Today, poor me...
-
Dexcom Marks Athenry Opening With Celebration of Commercial Production Milestone
ATHENRY, Ireland--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in continuous glucose monitoring, today officially opened its state-of-the-art manufacturing facility in Athenry, County Galway, marking a major milestone in the company’s investment in Ireland and its manufacturing presence in Europe, the Middle East and Africa. The official opening ceremony, attended by Minister for Public Expenditure, Infrastructure, Public Service Reform and Digitalisation, Jack Chambers, TD; Mi...
-
Welldoc Named to 2026 Fortune Best Workplaces in Health Care™ List by Great Place To Work®, Ranking No. 27
COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a leader in AI-powered health technology for complex conditions, today announced it has been named to the 2026 Fortune Best Workplaces in Health Care™ list by Great Place To Work® and Fortune magazine, ranking No. 27 in the small and medium category, up from No. 28 last year. The ranking is based on confidential feedback from nearly 222,000 employees at Great Place To Work Certified™ companies in the health care industry. “Our people are the reason Well...
-
OOG and the American Diabetes Association Announce Collaboration to Advance AI-Powered Diabetes Education for Healthcare Professionals
SANTA MONICA, Calif.--(BUSINESS WIRE)--OOG and the American Diabetes Association Announce Collaboration to Advance AI-Powered Diabetes Education for Healthcare Professionals...
-
A1c Below ADA Target in Six Months: New Nourish Data Shows the Impact of Dietitian-Led Care on Blood Sugar for Adults with Diabetes
NATIONAL HARBOR, Md.--(BUSINESS WIRE)--Nourish, the country's largest dietitian-led metabolic health clinic, presented results from a new real-world study this week at ObesityWeek, the premier conference focused on obesity research, treatment, prevention, and public policy. Among more than 2,000 adults with type 2 diabetes who stayed engaged in Nourish care for six months, working with a registered dietitian was associated with a clinically meaningful improvement in blood sugar.Key findings1.37...
-
New Vida Health Study Reports Real-World Obesity Care Outcomes Across More Than 10,000 Adults
SAN FRANCISCO--(BUSINESS WIRE)--Vida Health announced results from a real-world analysis of its total enrolled population, not a narrow or high-acuity subset....
-
Enterprise Therapeutics Granted EMA Orphan Medicinal Product Designation for Novel Cystic Fibrosis Therapy, ETD001
BRIGHTON, England--(BUSINESS WIRE)--Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of people with respiratory diseases, today announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has granted ETD001 designation as an orphan medicinal product for the treatment of cystic fibrosis. This follows the announcement earlier this year of a positive Phase 2...
-
Ollin Biosciences and Its Next-Generation Medicines for Patients with Vision-Threatening Eye Diseases to be Acquired
AUSTIN, Texas--(BUSINESS WIRE)--Ollin Biosciences, Inc. (“Ollin”), a privately-held clinical-stage biopharmaceutical company developing therapies for serious eye diseases, today announced it has entered into a definitive agreement to be acquired by Johnson & Johnson for $2.2 billion upfront with the potential for up to approximately $1.1 billion in additional regulatory and commercial milestone payments. Ollin was founded in 2023 with a mission to identify and accelerate the development of...
-
Ascensia Announces Winners of the 2026 This Is Diabetes Art and Photography Competition
BASEL, Switzerland--(BUSINESS WIRE)--Ascensia Diabetes Care, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE 6523), has announced the winners of the 2026 This Is Diabetes global art and photography competition, held in support of World Diabetes Day. The moment that changed everything This year’s theme, the moment that changed everything, invited people around the world to share a turning point in their experience of diabetes, from recognising the signs and receivi...
-
Tandem Mobi Now FDA Cleared as World’s First and Only Tubeless AID System with up to Seven Days of Wear
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration (FDA) clearance of Tandem Mobi for use as the world’s first and only tubeless automated insulin delivery system with up to 7 days of wear.1 A new Tandem Mobi tubeless cartridge and infusion set converts the current Tandem Mobi pump into a tubeless device that can help simplify diabetes management with less frequent si...